TY - JOUR
T1 - Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice
AU - Schmidt, Eric P.
AU - Damarla, Mahendra
AU - Rentsendorj, Otgonchimeg
AU - Servinsky, Laura E.
AU - Zhu, Bing
AU - Moldobaeva, Aigul
AU - Gonzalez, Alfredo
AU - Hassoun, Paul M.
AU - Pearse, David B.
PY - 2008/12
Y1 - 2008/12
N2 - High tidal volume (HVT) ventilation causes pulmonary endothelial barrier dysfunction. HVT ventilation also increases lung nitric oxide (NO) and cGMP. NO contributes to HVT lung injury, but the role of cGMP is unknown. In the current study, ventilation of isolated C57BL/6 mouse lungs increased perfusate cGMP as a function of VT. Ventilation with 20 ml/kg VT for 80 min increased the filtration coefficient (K f), an index of vascular permeability. The increased cGMP and K f caused by HVT were attenuated by nitric oxide synthase (NOS) inhibition and in lungs from endothelial NOS knockout mice. Inhibition of soluble guanylyl cyclase (sGC) in wild-type lungs (10 μM ODQ) also blocked cGMP generation and inhibited the increase in Kf, suggesting an injurious role for sGC-derived cGMP. sGC inhibition also attenuated lung Evans blue dye albumin extravasation and wetto-dry weight ratio in an anesthetized mouse model of HVT injury. Additional activation of sGC (1.5 μMBAY 41-2272) in isolated lungs at 40 min increased cGMP production and K f in lungs ventilated with 15 ml/kg VT. HVT endothelial barrier dysfunction was attenuated with a nonspecific phosphodiesterase (PDE) inhibitor (100 μM IBMX) as well as an inhibitor (10 μM BAY 60-7550) specific for the cGMP-stimulated PDE2A. Concordantly, we found a VT-dependent increase in lung cAMP hydrolytic activity and PDE2A protein expression with a decrease in lung cAMP concentration that was blocked by BAY 60-7550. We conclude that HVT-induced endothelial barrier dysfunction resulted from a simultaneous increase in NO/sGC-derived cGMP and PDE2A expression causing decreased cAMP.
AB - High tidal volume (HVT) ventilation causes pulmonary endothelial barrier dysfunction. HVT ventilation also increases lung nitric oxide (NO) and cGMP. NO contributes to HVT lung injury, but the role of cGMP is unknown. In the current study, ventilation of isolated C57BL/6 mouse lungs increased perfusate cGMP as a function of VT. Ventilation with 20 ml/kg VT for 80 min increased the filtration coefficient (K f), an index of vascular permeability. The increased cGMP and K f caused by HVT were attenuated by nitric oxide synthase (NOS) inhibition and in lungs from endothelial NOS knockout mice. Inhibition of soluble guanylyl cyclase (sGC) in wild-type lungs (10 μM ODQ) also blocked cGMP generation and inhibited the increase in Kf, suggesting an injurious role for sGC-derived cGMP. sGC inhibition also attenuated lung Evans blue dye albumin extravasation and wetto-dry weight ratio in an anesthetized mouse model of HVT injury. Additional activation of sGC (1.5 μMBAY 41-2272) in isolated lungs at 40 min increased cGMP production and K f in lungs ventilated with 15 ml/kg VT. HVT endothelial barrier dysfunction was attenuated with a nonspecific phosphodiesterase (PDE) inhibitor (100 μM IBMX) as well as an inhibitor (10 μM BAY 60-7550) specific for the cGMP-stimulated PDE2A. Concordantly, we found a VT-dependent increase in lung cAMP hydrolytic activity and PDE2A protein expression with a decrease in lung cAMP concentration that was blocked by BAY 60-7550. We conclude that HVT-induced endothelial barrier dysfunction resulted from a simultaneous increase in NO/sGC-derived cGMP and PDE2A expression causing decreased cAMP.
KW - Adenosine 3′,5′-cyclic monophosphate
KW - Atrial natriuretic peptide
KW - Endothelial permeability
KW - Guanosine 3′,5′-cyclic monophosphate
KW - Nitric oxide
KW - Phosphodiesterase 2A
UR - http://www.scopus.com/inward/record.url?scp=57149087477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=57149087477&partnerID=8YFLogxK
U2 - 10.1152/ajplung.90329.2008
DO - 10.1152/ajplung.90329.2008
M3 - Article
C2 - 18849438
AN - SCOPUS:57149087477
SN - 1040-0605
VL - 295
SP - L1056-L1065
JO - American Journal of Physiology - Lung Cellular and Molecular Physiology
JF - American Journal of Physiology - Lung Cellular and Molecular Physiology
IS - 6
ER -